Cardiovascular Implants

Companies announce agreement related to engineered tissue technologies

Published in Heart Disease Weekly, January 19th, 2003

Edwards Lifesciences Corporation (EW) and Cook Biotech Incorporated announced that the companies have entered into exclusive technology licensing and supply agreements to pursue the development of tissue-engineered heart valves and related cardiovascular implants using proprietary biomaterials developed by Cook Biotech.

Under terms of the agreements, Edwards obtains an exclusive worldwide license to submucosa tissue technology developed by Cook Biotech, as well as access to all related intellectual property rights for development of specific cardiovascular implants. Financial details of the agreements were not disclosed.

"Edwards is the world's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Heart Disease Weekly

Source: Heart Disease Weekly (2003-01-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry